UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.044

Sortiert nach

QXP: powerful, rapid computer algorithms for structure-based drug design

Journal of computer-aided molecular design, 1997-07, Vol.11 (4), p.333-344

1997

Volltextzugriff (PDF)

Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML

Blood, 2004-10, Vol.104 (8), p.2532-2539

2004

Volltextzugriff (PDF)

The art and practice of structure-based drug design: A molecular modeling perspective

Medicinal research reviews, 1996-01, Vol.16 (1), p.3-50

1996

Volltextzugriff (PDF)

Activity of Dual SRC-ABL Inhibitors Highlights the Role of BCR/ABL Kinase Dynamics in Drug Resistance

Proceedings of the National Academy of Sciences - PNAS, 2006-06, Vol.103 (24), p.9244-9249

2006

Volltextzugriff (PDF)

Modeling Communication Networks With Hybrid Systems

IEEE/ACM transactions on networking, 2007-06, Vol.15 (3), p.630-643

2007

Volltextzugriff (PDF)

A new TCP for persistent packet reordering

IEEE/ACM transactions on networking, 2006-04, Vol.14 (2), p.369-382

2006

Volltextzugriff (PDF)

Game Theoretic Stochastic Routing for Fault Tolerance and Security in Computer Networks

IEEE transactions on parallel and distributed systems, 2007-09, Vol.18 (9), p.1227-1240

2007

Volltextzugriff (PDF)

Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design

Journal of medicinal chemistry, 2001-12, Vol.44 (26), p.4524-4534

2001

Volltextzugriff (PDF)

Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

Journal of medicinal chemistry, 1999-10, Vol.42 (20), p.4088-4098

1999

Volltextzugriff (PDF)

Multiple Highly Diverse Structures Complementary to Enzyme Binding Sites: Results of Extensive Application of a de Novo Design Method Incorporating Combinatorial Growth

Journal of the American Chemical Society, 1994-06, Vol.116 (13), p.5560-5571

1994

Volltextzugriff (PDF)

Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases

Bioorganic & medicinal chemistry letters, 2003-09, Vol.13 (18), p.3067-3070

2003

Volltextzugriff (PDF)

Definition and display of steric, hydrophobic, and hydrogen bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: validation of a high-resolution graphical tool for drug design

Journal of medicinal chemistry, 1992-05, Vol.35 (10), p.1671-1684

1992

Volltextzugriff (PDF)

Aspartic Protease Inhibitors Designed from Computer-Generated Templates Bind As Predicted

Organic letters, 2001-07, Vol.3 (15), p.2309-2312

2001

Volltextzugriff (PDF)

A stochastic model of TCP and fair video transmission

IEEE INFOCOM 2003. Twenty-second Annual Joint Conference of the IEEE Computer and Communications Societies (IEEE Cat. No.03CH37428), 2003, Vol.2, p.1134-1144 vol.2

Bohacek, S.

2003

Volltextzugriff (PDF)

X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor

Journal of medicinal chemistry, 2001-03, Vol.44 (5), p.660-663

2001

Volltextzugriff (PDF)

Synthesis of novel cyclic protease inhibitors using Grubbs olefin metathesis

Bioorganic & medicinal chemistry letters, 1998-02, Vol.8 (4), p.357-360

1998

Volltextzugriff (PDF)

Design and Synthesis of Unsymmetrical Peptidyl Urea Inhibitors of Aspartic Peptidases

Organic letters, 2001-07, Vol.3 (15), p.2313-2316

2001

Volltextzugriff (PDF)

Modern computational chemistry and drug discovery: structure generating programs

Current opinion in chemical biology, 1997-08, Vol.1 (2), p.157-161

1997

Volltextzugriff (PDF)

Structure-Based Design of Novel Bicyclic Nonpeptide Inhibitors for the Src SH2 Domain

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3815-3819

2000

Volltextzugriff (PDF)

Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption

Bone (New York, N.Y.), 2001, Vol.28 (1), p.54-64

2001

Volltextzugriff (PDF)

Novel Protein Kinase Inhibitors: SMART Drug Design Technology

BioTechniques, 2003-06, Vol.34 (sup), p.S2-S15

2003

Volltextzugriff (PDF)

Practical Computation of Optimal Schedules in Multihop Wireless Networks

IEEE/ACM transactions on networking, 2011-04, Vol.19 (2), p.305-318

2011

Volltextzugriff (PDF)

Structure-based design and synthesis of a novel class of Src SH2 inhibitors

Bioorganic & medicinal chemistry letters, 1999-08, Vol.9 (16), p.2353-2358

1999

Volltextzugriff (PDF)

Linear dynamically varying LQ control of nonlinear systems over compact sets

IEEE transactions on automatic control, 2001-06, Vol.46 (6), p.840-852

2001

Volltextzugriff (PDF)

An efficient synthesis of a 4′-phosphonodifluoromethyl-3′-formyl-phenylalanine containing Src SH2 ligand

Bioorganic & medicinal chemistry letters, 1999-11, Vol.9 (21), p.3109-3112

1999

Volltextzugriff (PDF)

1 – 25 von 1.044

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(790)
Mit Volltextzugriff
(931)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(512)
Technology
(256)
Physical Sciences
(217)
Life Sciences & Biomedicine
(160)
Physics
(158)
Humans
(92)
Engineering
(89)
Exact Sciences And Technology
(85)
Materials Science
(81)
Animals
(72)
Chemistry
(71)
Engineering, Electrical & Electronic
(64)
Materials Science, Multidisciplinary
(64)
Instruments & Instrumentation
(63)
Female
(52)
Physics, Applied
(50)
Physics, Condensed Matter
(47)
Male
(46)
Computer Science
(44)
Health Aspects
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

QXP: powerful, rapid computer algorithms for structure-based drug design

Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML

The art and practice of structure-based drug design: A molecular modeling perspective

Activity of Dual SRC-ABL Inhibitors Highlights the Role of BCR/ABL Kinase Dynamics in Drug Resistance

Modeling Communication Networks With Hybrid Systems

A new TCP for persistent packet reordering

Game Theoretic Stochastic Routing for Fault Tolerance and Security in Computer Networks

Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design

Discovery of Potent and Selective SH2 Inhibitors of the Tyrosine Kinase ZAP-70

Multiple Highly Diverse Structures Complementary to Enzyme Binding Sites: Results of Extensive Application of a de Novo Design Method Incorporating Combinatorial Growth

Bone-Targeted 2,6,9-Trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases

Definition and display of steric, hydrophobic, and hydrogen bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: validation of a high-resolution graphical tool for drug design

Aspartic Protease Inhibitors Designed from Computer-Generated Templates Bind As Predicted

A stochastic model of TCP and fair video transmission

X-ray Structure of Citrate Bound to Src SH2 Leads to a High-Affinity, Bone-Targeted Src SH2 Inhibitor

Synthesis of novel cyclic protease inhibitors using Grubbs olefin metathesis

Design and Synthesis of Unsymmetrical Peptidyl Urea Inhibitors of Aspartic Peptidases

Modern computational chemistry and drug discovery: structure generating programs

Structure-Based Design of Novel Bicyclic Nonpeptide Inhibitors for the Src SH2 Domain

Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption

Novel Protein Kinase Inhibitors: SMART Drug Design Technology

Practical Computation of Optimal Schedules in Multihop Wireless Networks

Structure-based design and synthesis of a novel class of Src SH2 inhibitors

Linear dynamically varying LQ control of nonlinear systems over compact sets

An efficient synthesis of a 4′-phosphonodifluoromethyl-3′-formyl-phenylalanine containing Src SH2 ligand

Suchergebnisse filtern